Citadel Advisors’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.6K | Sell |
11,890
-134
| -1% | -$548 | ﹤0.01% | 5467 |
|
|
2025
Q1 | $20.7K | Sell |
12,024
-2,265
| -16% | -$3.9K | ﹤0.01% | 5579 |
|
|
2024
Q4 | $20.9K | Sell |
14,289
-2,947
| -17% | -$4.3K | ﹤0.01% | 5641 |
|
|
2024
Q3 | $29.5K | Buy |
17,236
+5,388
| +45% | +$9.21K | ﹤0.01% | 5251 |
|
|
2024
Q2 | $25K | Buy |
+11,848
| New | +$25K | ﹤0.01% | 5358 |
|
|
2023
Q2 | – | Sell |
-15,295
| Closed | -$16.7K | – | 6246 |
|
|
2023
Q1 | $16.7K | Sell |
15,295
-3,045
| -17% | -$3.32K | ﹤0.01% | 5425 |
|
|
2022
Q4 | $20.5K | Buy |
18,340
+5,225
| +40% | +$5.85K | ﹤0.01% | 5553 |
|
|
2022
Q3 | $12K | Buy |
13,115
+992
| +8% | +$908 | ﹤0.01% | 5621 |
|
|
2022
Q2 | $19K | Buy |
+12,123
| New | +$19K | ﹤0.01% | 5728 |
|
|
2021
Q2 | – | Sell |
-18,421
| Closed | -$123K | – | 6837 |
|
|
2021
Q1 | $123K | Buy |
+18,421
| New | +$123K | ﹤0.01% | 5727 |
|